The landscape of weight management is rapidly evolving with the emergence of several promising injectable therapies. the GLP-1/GIP dual agonist, Cagrilintide , a newer peptide, and a GLP-1 receptor agonist https://nexaphresearchpeptides.com/product-category/growth-hormone-peptides/